JournalsHub
.online
Find My Journal
RH

Roy S. Herbst

Yale New Haven Hospital US

ORCID 0000-0003-2535-5847
1,328
Publications
93,024
Citations
134
H-Index
484
i10-Index
6.54
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

1,316 total

The biology and management of non-small cell lung cancer

Roy S. Herbst, Daniel Morgensztern, Chris Boshoff - Nature, 2018
Cited by 4,861 OpenAlex

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia et al. - The Lancet, 2015
Cited by 6,485 OpenAlex

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz, Gregg Fine, Omid Hamid et al. - Nature, 2014
Cited by 5,225 OpenAlex

Lung Cancer PDF

Roy S. Herbst, John V. Heymach, Scott M. Lippman - New England Journal of Medicine, 2008
Cited by 2,380 OpenAlex

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager et al. - JAMA, 2003
Cited by 2,534 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (646) Cancer Immunotherapy and Biomarkers (358) Lung Cancer Research Studies (202) Cancer Genomics and Diagnostics (179) Lung Cancer Diagnosis and Treatment (168)

Affiliations

AstraZeneca (United Kingdom)
GB 2009 - 2006
Northwestern University
US 2012 - 2005
Roche (Switzerland)
CH 2020 - 2020
Hebron University
PS 2002 - 2002
University of Maryland, Baltimore
US 2013 - 2011

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now